BioNumerik acquires 32-process Cray SV1Seattle 08 January 2001 Cray did get an order for a 32-processor Cray SV1 supercomputer from BioNumerik Pharmaceuticals, Inc. The order includes an option to acquire future Cray technologies. The machine will be used to do research on cancer-fighting drugs
BioNumerik will use the new Cray SV1 system - which nearly doubles its existing computing capacity, memory and bandwidth - to tackle even larger quantum chemistry problems critical for creating new cancer-fighting drugs. Specifically, BioNumerik runs complex GAUSSIAN, AMBER and its own proprietary applications on its Cray supercomputers and then tests the system's predictions in the lab. By blending the latest lab technologies with high-performance computing, BioNumerik is working to significantly shorten development time and more cost-effectively create new potentially life-saving drugs.
Financial terms were not disclosed.
Installation and acceptance of the Cray SV1 supercomputer at BioNumerik's San Antonio, Texas, facility was completed in December 2000.
More than 100 Cray SV1 systems have been installed since general availability began in August 1999. Half of that volume has come from outside of the United States.
Ad Emmen [News on Advanced IT] [Calendar] [Analysis] [IT in Medicine] |
 |